Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(2,3-difluoro-benzyl)-4-sulfamoyl-benzamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N-(2,3-difluoro-benzyl)-4-sulfamoyl-benzamide is an experimental small molecule belonging to the class of n-benzylbenzamides and sulfonamides. It acts as a potent inhibitor of carbonic anhydrase II (CA II), an enzyme involved in the reversible hydration of carbon dioxide. Inhibition of CA II can affect physiological processes such as acid-base balance and fluid secretion. The compound has not been approved for any indication and is primarily studied for its biochemical properties and potential pharmaceutical applications[1][5][9]. Its difluorobenzyl group may enhance metabolic stability and biological activity compared to non-fluorinated analogs[5].
- Other names
- 4-(aminosulfonyl)-N-((2,3-difluorophenyl)methyl)benzamideN-(2,3-difluorobenzyl)-4-sulfamoylbenzamideN-[ (2,3-difluorophenyl)methyl ] - 4 - sulfamoyl - benzamide
02
Targets
CA2 (Carbonic Anhydrase 2)
Beyond the preview
Go deeper on N-(2,3-difluoro-benzyl)-4-sulfamoyl-benzamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-(2,3-difluoro-benzyl)-4-sulfamoyl-benzamide.